Skip to main content
All lobbying filings

2359 STRATEGIES

Lobbying for TRAVERE THERAPEUTICS · Biopharmaceutical company

 Filing 1st Quarter - Report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 19, 2025
Income
$12,000.00
What the client paid this registrant for the period.
Client based in
California

Official filing document

 Lobbyists on this filing 1
  • CHARLES DUJON
    Previously held: Legislative Director (1998-2013), Rep. Jesse Jackson, Jr.

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 1
  • HR 1518
    New Era of Preventing End-Stage Kidney Disease Act
 Lobbying activity 5
Medicare/Medicaid

H.R.1518 - New Era of Preventing End-Stage Kidney Disease Act

Health Issues

H.R.1518 - New Era of Preventing End-Stage Kidney Disease Act

Medical/Disease Research/Clinical Labs

H.R.1518 - New Era of Preventing End-Stage Kidney Disease Act

Pharmacy

H.R.1518 - New Era of Preventing End-Stage Kidney Disease Act

Taxation/Internal Revenue Code

H.R.1518 - New Era of Preventing End-Stage Kidney Disease Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem